companies / autoimmunitybiologicsolutions-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 3,209,2333.2M | D D |
|---|---|---|
| founded | null | |
| hq | HOUSTON, TX | |
| industry | unknown | |
| stage | null |
Clinical-stage biotech developing monoclonal antibodies that target soluble IL-7 receptor to dampen autoimmune amplification. Initial programs focus on genetically defined patients with multiple sclerosis and lupus nephritis. Selective sIL7R targeting aims to correct the immune defect rather than broadly suppress immunity.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-11-08 | Funding round | 3,209,2333.2M | null | D D |
| person | role | src |
|---|---|---|
| Brock Reeve | director | D |
| Eugene Williams | director | D |
| Eugene Williams | executive | D |
| Gaddiel Galarza-Munoz | executive | D |
| Jimmy Lu | director | D |
| Mariano Garcia-Blanco | director | D |
| fact | status | src |
|---|---|---|
| Funding round, $3.2M | sourced | D D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28latest_round: Funding round, $3.2M, 2024-11-08 → Funding round, $3.2M, 2024-11-08, D 2026-09-25 | latest_round | Funding round, $3.2M, 2024-11-08 → Funding round, $3.2M, 2024-11-08 | D 2026-09-25 |
| 2026-09-28total_raised: 3200000 → 3209233, D 2026-09-25 | total_raised | 3200000 → 3209233 | D 2026-09-25 |
| 2026-09-25latest_round: seed, $3.2M, 2024-11-08 → Funding round, $3.2M, 2024-11-08, D |
| latest_round |
| seed, $3.2M, 2024-11-08 → Funding round, $3.2M, 2024-11-08 |
| D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes